Literature DB >> 15607252

Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles.

M Perrut1, J Jung, F Leboeuf.   

Abstract

In this first of two articles, we discuss some issues surrounding the dissolution rate enhancement of poorly-soluble active ingredients micronized into nano-particles using several supercritical fluid particle design processes including rapid expansion of supercritical solutions (RESS), supercritical anti-solvent (SAS) and particles from gas-saturated solutions/suspensions (PGSS). Experimental results confirm that dissolution rates do not only depend on the surface area and particle size of the processed powder, but are greatly affected by other physico-chemical characteristics such as crystal morphology and wettability that may reduce the benefit of micronization.

Mesh:

Substances:

Year:  2005        PMID: 15607252     DOI: 10.1016/j.ijpharm.2004.09.007

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  19 in total

1.  Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats.

Authors:  Shubhada Mangrulkar; Pranav Shah; Sonali Navnage; Priyanka Mazumdar; Dinesh Chaple
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

Review 2.  An overview on in situ micronization technique - An emerging novel concept in advanced drug delivery.

Authors:  K R Vandana; Y Prasanna Raju; V Harini Chowdary; M Sushma; N Vijay Kumar
Journal:  Saudi Pharm J       Date:  2013-05-29       Impact factor: 4.330

3.  Pharmacokinetics and Tissue Disposition of Nanosystem-Entrapped Betulin After Endotracheal Administration to Rats.

Authors:  Olga N Pozharitskaya; Marina V Karlina; Alexander N Shikov; Vera M Kosman; Valery G Makarov; Eudald Casals; Jessica M Rosenholm
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

4.  Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation.

Authors:  Sameer Sharma; Praveen Sher; Shraddha Badve; Atmaram P Pawar
Journal:  AAPS PharmSciTech       Date:  2005-12-07       Impact factor: 3.246

5.  Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.

Authors:  Ying Li; Da-Jian Yang; Shi-Lin Chen; Si-Bao Chen; Albert Sun-Chi Chan
Journal:  Pharm Res       Date:  2007-09-08       Impact factor: 4.200

6.  Self-built supercritical CO2 anti-solvent unit design, construction and operation using carbamazepine.

Authors:  Dan Meng; James Falconer; Karen Krauel-Goellner; John J J J Chen; Mohammed Farid; Raid G Alany
Journal:  AAPS PharmSciTech       Date:  2008-08-09       Impact factor: 3.246

7.  Increasing the dissolution rate of itraconazole processed by gas antisolvent techniques using polyethylene glycol as a carrier.

Authors:  Angela Mary Barrett; Fariba Dehghani; Neil R Foster
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

8.  Preparation and characterization of micronized artemisinin via a Rapid Expansion of Supercritical Solutions (RESS) Method.

Authors:  Huimin Yu; Xiuhua Zhao; Yuangang Zu; Xinjuan Zhang; Baishi Zu; Xiaonan Zhang
Journal:  Int J Mol Sci       Date:  2012-04-23       Impact factor: 6.208

9.  Chitosan and chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol.

Authors:  Amol S Shete; Adhikrao V Yadav; Srinivasa M Murthy
Journal:  Daru       Date:  2012-12-13       Impact factor: 3.117

10.  Influence of the efavirenz micronization on tableting and dissolution.

Authors:  Eduardo Costa Pinto; Flávia Almada do Carmo; Thiago da Silva Honório; Rita de Cássia da Silva Ascenção Barros; Helena Carla Rangel Castro; Carlos Rangel Rodrigues; Valéria Sant'anna Dantas Esteves; Helvécio Vinícius Antunes Rocha; Valeria Pereira de Sousa; Lucio Mendes Cabral
Journal:  Pharmaceutics       Date:  2012-09-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.